Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study On The Efficacy Of Macugen Injections In Patients With Neovascular Age-Related Macular Degeneration (AMD) In Real Life (Macureli Study).

NCT00549055 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00549055
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00549055 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study On The Efficacy Of Macugen Injections In Patients With Neovascular Age-Related Macular Degeneration (AMD) In Real Life (Macureli Study).
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
November 30, 2007
Completion date
October 31, 2009
Enrollment
38 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

neovascular age-related macular degeneration